Metabolism Changes in Young People with Lymphoma
Treatments studied
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at how your body's metabolism (processing of food and medicine) changes after you start treatment for lymphoma. It uses two safe, commonly used drugs (omeprazole and dextromethorphan) to measure these changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 6 and 25 years old.
- You have been newly diagnosed with Hodgkin or Non-Hodgkin lymphoma, and this is your first cancer diagnosis.
- You can swallow pills or take medications through a feeding tube.
- You are not allergic to the study drugs (omeprazole or dextromethorphan).
- You do not have life-threatening organ damage (e.g., to your liver, kidneys, or stomach).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special lab testing (“omics”) on people with certain fast-growing B-cell lymphomas to find results that can help with diagnosis and predicting outcomes. It may help by improving how clinicians identify the lymphoma type and forecast how it may behave.
This study looks at how social and genetic factors affect the health and quality of life of young adults who have survived Hodgkin or non-Hodgkin lymphoma. It may help doctors better support survivors after treatment.
This trial tests whether a lower dose of radiation, guided by PET scans, is safe and effective for people with early-stage but unfavorable Hodgkin lymphoma. It aims to reduce side effects while keeping the treatment strong.
This study tests whether a Mediterranean-style diet and home exercise plan can improve health and recovery in people who have been treated for non-Hodgkin or Hodgkin lymphoma with chemotherapy. You may also be placed on a waitlist/control group to compare outcomes.
This study looks at how “early aging” changes show up during treatment in young adults with cancer. It may help doctors better understand health effects during curative therapy and improve care for people your age.
This trial studies a treatment approach for children and teens newly diagnosed with lymphoblastic lymphoma. It may help doctors choose therapies based on genetic risk information from lab testing done on tumor samples.
Hear when a new Hodgkin Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.